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Article Info Abstract
Introduction: Breast cancer stem cell with 
CD44hi/CD24lo phonotype is described 
having stem cell properties and represented 
as the main driving factor in breast cancer 
initiation, growth, metastasis and low 
response to anti-cancer agents. Glucose-
regulated proteins (GRPs) are heat shock 
protein family chaperons that are charged 
with regulation of protein machinery 
and modulation of endoplasmic reticulum homeostasis whose important roles in stem cell 
development and invasion of various cancers have been demonstrated. Here, we investigated 
the expression levels of GRP78 and GRP94 in CD44hi/CD24lo phenotype breast cancer stem cells 
(BCSCs).
Methods: MCF7, T-47D and MDA-MB-231 breast cancer cell lines were used. CD44hi/CD24lo 
phenotype cell population were analyzed and sorted by fluorescence-activated cell sorting 
(FACS). Transcriptional and translational expression of GRP78 and GRP94 were investigated by 
western blotting and quantitative real time PCR.
Results: Results showed different proportion of CD44hi/CD24lo phenotype cell population in 
their original bulk cells. The ranking of the cell lines in terms of CD44hi/CD24lo phenotype cell 
population was as MCF7<T-47D<MDA-MB-231. Our results also indicated that CD44hi/CD24lo 
phenotype cells exhibited higher mRNA and protein expression level of GRP78 and GRP94 
compared to their original bulk cells.
Conclusion: Our results show a relationship between overexpression of GRP78 and GRP94 and 
exhibiting CD44hi/CD24lo phenotype in breast cancer cells. We conclude that upregulation of 
GRPs may be an important factor in the emergence of CD44hi/CD24lo phenotype BCSCs features.
Introduction
Cancer stem cell theory propagates cancers arise by di-
rection of minor subset of stem/progenitor cells inside tu-
mors.1 Breast cancer stem cells (BCSCs) with CD44hi/CD-
24lo phenotype inside breast tumors are known to have tu-
mor-initiating behavior with stem cell-like characteristics, 
enhanced invasive properties and radiation resistance.2 
CD44hi/CD24lo phenotype cells were able to self-renewal, 
to maintain its subpopulation in tumor and to differenti-
ate into downstream tumor cells resembling the composi-
tion of the original tumor.2,3 Evidences support prominent 
role of CD44hi/CD24lo phenotype BCSCs in metastasis, re-
sistant to chemotherapy and therefore responsible for can-
cer relapse.3,4 These cells exhibit a distinct gene expression 
signature that allows them to act as core engine for breast 
cancer malignancy.5 CD44hi/CD24lo phenotype BCSCs 
possess many genetic and epigenetic features which are 
common in both cancerous and normal stem cells. It is 
due to significant molecular properties including altered 
response mechanism to DNA damage in BCSC that grant 
the cells to survival, invasion and chemoresistance.6
Essentially, rapid growth of tumor leads to undesirable 
metabolic environment such as, hypoxic and nutrient de-
prived, having reduced amounts of both amino acids and 
glucose. Nutrient and hypoxic stressors damage protein 
machinery and consequently cause unfolded/misfold-
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ed protein accumulation in endoplasmic reticulum (ER) 
lumen. This phenomenon eventually activates unfolded 
protein response and ER stress.7,8 ER stress acts as regu-
lator of cell homeostasis in response to aberrant synthe-
sis machinery through controlling calcium balance and 
employment of ER chaperon proteins.8 Glucose Regulat-
ed Protein 78 and 94 kDa (GRP78 and GRP94) are heat 
shock protein family molecular chaperons that are found 
in the lumen of the ER. GRPs are essential regulator of 
ER function due to their function in protein translocation, 
folding and assembly, targeting malfolded protein for deg-
radation, ER Ca2+ binding and controlling the initiation of 
ER stress sensors.9,10 Expression of GRPs is also increases 
under growth conditions in particular glucose starvation. 
Studies showed that GRPs were essential for embryonic 
cell growth and its function is obligatory for early embry-
onic development.10-12 
Altered GRPs expression has been reported in various can-
cers. GRPs are thought to play key roles in cancer cell sur-
vival, proliferation, invasion and several pathologic condi-
tions such as poor prognosis and resistance to anticancer 
therapy.9,11,13 GRPs exhibit an anti-apoptotic function to 
block activity of apoptosis and autophagy, and eventually 
leading to death inhibition and increased cell survival.13-15 
Emerging evidences suggest that GRPs may be exploited 
as negative factors for death inducing approaches such 
as radiotherapy as well as may be a diagnostic marker for 
breast cancer chemo-responsiveness.15 It has been shown 
that chemotherapy against breast cancer leads to increas-
ing level of GRPs in viable tumor tissues. Recent studies re-
ported that cell surface GRP78 are required for regulation 
of hematopoietic, fetal and adult mammary stem cells qui-
escence that aid the stem cells to restore homeostasis.16,17 
The reports also revealed pivotal function of GRP78 and 
GRP94 in mammary tissue development.18,19 Interestingly, 
a recent report demonstrated that expression of GRP78 
increases resistance of the breast cancer stem cell-like 
cells against radiotherapy.20 Moreover, we recently showed 
that chemical-induced ER stress in MCF7 cells suppress-
es CD44hi/CD24lo phenotype BCSCs subpopulation and 
eventually inhabits cell migration and invasion.21 Relying 
on these findings, we believe that ER stress and CD44hi/
CD24lo phenotype BCSCs may be exploited as potential 
targets to use in treatment of breast cancer. In this study, 
we aimed to investigate expression status of ER shaperons 
GRP78 and GRP94 in BCSCs. 
Materials and methods
Cell culture
MCF7, T-47D and MDA-MB-231 breast cancer cell lines 
were obtained from American Type Tissue Culture Col-
lection (Manassas, USA). The cells were grown in Dul-
becco’s modified eagle medium (DMEM)/F12 containing 
10% fetal calf serum (FCS; both from Gibco, Rockford, 
USA), supplemented with 2 mmol/mL L-glutamine (Gib-
co, Rockford, USA) by incubation at 37°C in a 5% CO2 
humidified incubator. After the cell culture reached 80% 
confluence, the cells were trypsinized with 0.25% trypsin 
(Sigma-Aldrich, St. Luis, USA) and harvested.
Flow cytometry and fluorescence-activated cell sorting 
(FACS)
FITC-conjugated monoclonal mouse anti-human CD44 
IgG (#555478) and PE-conjugated monoclonal mouse 
anti-human CD24 IgG (#555428) antibodies and their 
respective isotype controlswere used (all from BD Bio-
sciences, San Diego, USA). All flow cytometry and FACS 
procedures were done as described previously.22
Real time quantitative PCR
Total RNA from original cell lines and sorted CD44hi/
CD24lo phenotype cells was extracted using TRIzol re-
agent (Invitrogen, Waltham, USA) according to protocol 
described previously.23 cDNA synthesis from total RNA 
was carried out using Transcriptor High Fidelity cDNA 
Synthesis® kit (Roche, Basel, Switzerland) by applying 
the oligo (dT)18 primer pairs following the manufacturer’s 
instructions. Whole real time quantitative PCR reactions 
were done by employing an Applied Biosystems® 7500 
real time PCR system and using TaqMan® Universal PCR 
Master Mix following the manufacturer’s instructions. 
Aequence of used primers and probes are shown in Table 
1. Specific primers for PCR amplification were designed 
using IDT PrimerQuest software24 and synthesized by 
Biomers Inc. (Ulm, Germany). The cycle thresholds re-
sults were normalized to GAPDH as endogenous control. 
The expression levels were calculated by 2ΔΔct.
Western blotting
Polyclonal rabbit anti-human GRP78 IgG (#G9043), Poly-
clonal goat anti human GRP94 IgG (#G4545), rabbit anti 
human GAPDH IgG (#G9545) and HRP conjugated goat 
anti rabbit IgG (#A0545) were purchased from Sigma-Al-
Table 1. Sequences of primers and TaqMan probes used for quantitative real time qPCR
Target cDNA (RefSeq) Sequence
GRP78 (NM_005347.4)
Forward: 5′-GGTGGATCACAAGGTCAAGAG-3′
Probe: 5’-/FAM/TGCCAACATGGTGAAACTCCATCTCT/BHQ/-3’
Reverse: 5′-CTACCACGCCCAGCTAATTT-3′
GRP94 (NM_003299.2)
Forward: 5’-GGCAAGGACATCTCTACAAA-3’
Probe: 5’-/FAM/ATTTGAAATTAATCCCAGACACCCGCTGA/BHQ/-3’
Reverse: 5’-CCTTAATTCGTCGAAGCATGT-3’
GAPDH (NM_002046.4)
Forward: 5’- TCCAGAACATCATCCCTGC-3’
Probe: 5’-/FAM/TGTGGGCAAGGTCATCCCTGAG/BHQ/-3’
Reverse: 5’-CAGTGAGCTTCCCGTTCA-3’
Overexpression of GRP78 and GRP94 in breast cancer stem cells
BioImpacts, 2016, 6(2), 105-110 107
drich (St. Louis, MO, USA). Total proteins from the cells 
were extracted using ReadyPreb protein extraction kit 
(Bio-Rad Laboratories, Berkeley, USA) following the mao-
nufacturer’s instructions. The protein samples were prepp-
raed by adding a same volume of 4x lammeli buffer and 
then incubation at 95°C for 5 minutes. Amount 20 µg of 
total protein from each sample was run in %8 gel (10% 
acrylamide, 0.4% Tris, 0.1% SDS, 0.1% ammonium per-
sulfate, 0.1% tetramethylethylenediamine (TEMED) and 
89.3% ddH2O) at 40 mA electric current for an hour. Af-
ter the electrophoresis, proteins were transfered onto nit-
rocellulose membrane (Bio-Rad Laboratories, Berkeley, 
USA) by overnight wet blotting. Blocking of membrane 
was done with 3% non-fat milk solution for an hour in 50 
rpm agitation. The immunoblotting was accomplished by 
incubation of the membrane with 100 ng/mL (1:1000) of 
primary antibody solution and then 50 ng/mL (1:2000) of 
secondary antibody each for 2 hours at room temperature. 
At the end of the blotting, the membrane was incubated in 
Immun-star WesternC Chemiluminescent (Bio-Rad Lab-
oratories, Berkeley, USA; #170-5070) substrate solution 
for 5 minutes then imaged by a gel documentation system 
(Bio-Rad Laboratories, Berkeley, USA). 
Statistical analysis
The statistical significances were considered applying 
two-tailed analysis of variance (ANOVA) using GraphPad 
Prism® V.6.00 software (GraphPad software Inc., La Jolla, 
USA). A p<0.05 was considered as statistically significant.
Results
Human breast cancer cell lines differ in the CD44hi/
CD24lo phenotype BCSCs subpopulation
Due to heterogeneity of breast tumor we selected the cell 
lines regarding distinct characteristics in order to reach 
confident information. MCF7 and T47-D are estrogen 
receptor positive luminal A cell lines that can only form 
tumor in the presence of estrogen and often response to 
anti-estrogen chemotherapy. However, MDA-MB-231 is 
a claudin low and triple negative breast cancer (TNBC) 
cell line which is more aggressive with lower response 
to chemotherapy compared to the other cells.25 We an-
alyzed CD44hi/CD24lo phenotype BCSC subpopulation 
and sorted them into a serum free medium and then ex-
tracted RNA and protein immediately. As flow cytometry 
result, the mean percentage of CD44hi/CD24lo phenotype 
cells in MCF7, T-47D and MDA-MB-231 cells was found 
as respectively, 0.97% (SD=0.15), 1.43% (SD=0.2) and 
4.1% (SD=0.95; Fig. 1). The results showed a significant 
different in the subpopulation of CD44hi/CD24lo pheno-
type cells between the cell lines (p<0.01; Fig. 1). This data 
shows that subpopulation of CD44hi/CD24lo vary in differ-
ent types of breast cancer cell lines. 
Overexpression of GRP78 and GRP94 in CD44hi/CD24lo 
phenotype BCSCs 
To determine expression level of GRPs in the original 
breast cancer cell lines and theirs CD44hi/CD24lo pheno-
type cells, we analyzed transcriptional and translational 
expression levels of GRP78 and GRP94 in both bulk and 
FACS sorted CD44hi/CD24lo phenotype cells. Western blot 
analysis result showed a higher GRP78 and GRP94 protein 
expressions in the CD44hi/CD24lo phenotype cells in com-
parison with their original cell lines (Fig. 2A). Similarly, 
the quantitative real time PCR analysis showed that RNA 
expression of GRP78 and GRP94 was considerably higher 
in the CD44hi/CD24lo phenotype cells isolated from MCF7 
(p<0.01), T-47D (p<0.01) and MDA-MB-231 (p<0.01) 
compared with their original cells (Fig. 2B). These re-
sults indicate that CD44hi/CD24lo phenotype BCSCs show 
a higher level of expression of GRP78 and GRP94 when 
compared with their original cell lines.
Discussion 
In this study, we investigated GRP78 and GRP94 gene 
expression in the CD44hi/CD24lo phenotype cell subpop-
ulations of MCF7, T-47D and MDA-MB-231 cell lines. 
CD44hi/CD24lo cells in breast cancers are represented pos-
sessing progenitor/stem cell properties and were known 
as core engine of tumor growth, invasion, and resistance 
to anti-cancer agents. Positive impact of BSCS population 
in generation of tumor in animal models, metastasis and 
response to anti-cancer therapies has been reported pre-
viously.1–6 In present study we showed different propor-
tion of CD44hi/CD24lo phenotype cell subpopulation in 
MCF7, T-47D and MDA-MB-231 cell lines. we found that 
MCF7 and T-47D cells were contained significant pro-
portion of CD44hi/CD24lo cells while MDA-MB-231 cell 
line had more CD44hi/CD24lo phenotype cells. This may 
have purported the relation of BCSC subpopulation with 
invasion features of breast cancers at least in vitro condi-
tion. Its demonstrated that the tendency of breast tumors 
to invasion is linked to their BCSC subpopulation inside 
the tumors. 
Previous studies reported a distinct gene expression pro-
file in CD44hi/CD24lo phenotype BCSCs. They suggest 
Fig. 1. Distinct rate of CD44hi/CD24lo phenotype cell subpopulation 
in breast cancer cell lines. (A) Flow cytometry dot plate results of 
CD44hi/CD24lo phenotype cell subpopulation in breast cancer cell 
lines. Cells in Q4 is correspond to CD44hi/CD24lo phenotype cells. 
An isotype antibodies corresponding to MDA-MB-231 cells was 
used as control. (B) Percentage of CD44hi/CD24lo phenotype cell 
subpopulation which was identified in breast cancer cell lines by. 
* p < 0.05, ** p < 0.01.
Nami et al
BioImpacts, 2016, 6(2), 105-110108
that holding unique genetic and epigenetic feature may be 
the main productive trend of BCSCs to exhibit stemness 
properties.26 Here, we showed higher levels of GRP78 and 
GRP94 expression in CD44hi/CD24lo phenotype BCSCs 
derived from MCF7, T-47D and MDA-MB-231 cell lines 
(Fig. 3). Significant function of GRPs in developmental 
processes and stem cell biology implicates that GRPs may 
be key factors for stem cell to manifest pluripotency be-
havior, although the exact mechanism remains unknown. 
Thus we speculate that overexpressed GRP78 and GRP94 
in BCSCs may due to of the molecular regulators which 
push the cells to emerge progenitor/stem cell like behav-
ior. In other words, higher level GRPs in the cells may 
arise from stem cell-like function in these cells. Regard-
ing to a rational theory suggesting cancer stem cell origins 
from normal somatic stem cells, it is more probable to 
note higher levels of GRP78 and GRP94 are as the com-
mon features between cancerous and normal stem cells. 
GRPs are essential for ER homeostasis and cell survival 
under ER stress. GRPs evacuate malfolded proteins in 
ER lumen and their assistance in modulation of homeo-
stasis made it as advantageous factor for tumor survival 
Fig. 2. Overexpression of GRP78 and GRP94 in CD44hi/CD24lo 
phenotype BCSCs (A) Western blot protein analysis showed high 
levels of GRP78 and GRP94 protein expression in CD44hi/CD24lo 
phenotype cells. (B) Real time quantitative PCR results exhibited 
multiplied transcriptional expression of GRP78 and GRP94 in 
CD44hi/CD24lo phenotype cells compared with relevant original 
bulk cells. GAPDH was used as housekeeping gene control. 
* p < 0.05, ** p< 0.01.
Fig. 3. Model summarizing the expression gradient of GRP78 and 
GRP94 in CD44hi/CD24lo phenotype BCSCs in MCF-F, T-47D and 
MDA-MB-231 cells. CD44hi/CD24lo phenotype cell subpopulation 
in the cells was detected as MCF7<BT47D<MDA-MB-231. 
CD44hi/CD24lo phenotype cells showed higher level of expression 
of GRPs than their original bulk cells (vertical gradients). 
Expression of GRPs in the CD44hi/CD24lo phenotype cells 
derived from original bulk cells was detected as MCF7CD44hi/CD24lo 
<BT47DCD44hi/CD24lo <MDA-MB-231CD44hi/CD24lo (horizontal gradients). 
There is a positive correlation between exhibition of CD44hi/
CD24lo phenotype and expression of GRPs in the cell lines.
and resistance in stressful conditions. GRP78 was found 
as an overexpressed gene during breast cancer invasion 
specially metastasis to lymph nodes.27 A recent investiga-
tion illustrated a novel GRP78 function in deactivation of 
apoptotic paths in breast cancer. According to this report, 
GRP78 inhibits BIK protein binding to BCL-2 in breast 
cancer cells. This suggests that GRP78 may be a responsi-
ble  factor in endocrine resistance in breast cancer.15 High-
er level of GRP94 expression was also observed in breast 
carcinoma in comparison with normal tissue.13 Moreover, 
investigating GRP94 expression in HER2 overexpressed 
breast cancers, revealed that inhibition of GRP94 could 
destabilizes HER2 and inhibited RAF1–MAPK surviv-
al signaling at tumor cell membrane.28 HER2 leads to 
activation of different downstream signaling cascades, 
including the MAPK, a key pathway for proliferation, 
and also a set of critical factors which may lead to in-
creased cell proliferation, motility, decreased apoptosis, 
angiogenesis and resistance against therapy. Silencing of 
GRP94 causes inhibition of proliferation and migration 
in MDA-MB-231 breast cancer cell line.27 These data may 
support the notion that overexpression of GRPs may be 
a hallmark for breast malignancy that it has been inter-
twined with breast tumor molecular abnormalities. Thus, 
it may think to be a part of breast cancer pathophysiology. 
In addition, it can exclude ER stress-mediated apoptosis 
and autophagy in vitro and in vivo tumor models. Many 
studies demonstrated ER stress role in suppression of can-
cers.29,30 In a recent study, we demonstrated that CD44hi/
CD24lo phenotype BCSCs are vulnerable against ER stress. 
Induced ER stress in breast cancer bulk cells inhibits cell 
proliferation and invasion via promoting cell death in 
parallel with suppressed subpopulation of CD44hi/CD24lo 
phenotype cells.21 In the other hand, autophagy is a con-
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What is current knowledge?
√ Subpopulation of breast cancer stem cells inside breast 
tumor has a relationship with tumor malignancy, invasion 
and resistance against therapy. 
√ Chaperon proteins GRP78 and GRP94 are known to 
play roles in ER stress-mediated death and survival of both 
normal stem cells and cancer cells. 
√ The expression of GRP78 and GRP94 genes in breast cancer 
stem cells has not been elevated yet.
What is new here?
√ Distinct subpopulation of CD44hi/CD24lo phenotype breast 
cancer stem cells can be seen inside different breast cancer 
cell lines.
√ GRP78 and GRP94 are overexpressed in CD44hi/CD24lo 
phenotype breast cancer stem cells.
√ There is a positive correlation between upregulation of 
GRP78 and GRP94 and subpopulation of CD44hi/CD24lo 
phenotype breast cancer stem cells.
Research Highlightssequence phenomenon of ER stress.
31 In another report, 
we showed that CD44hi/CD24lo phenotype cancer stem 
cell subpopulation declines under autophagic condition.22 
GRPs play crucial negatively regulatory roles in ER stress. 
GRP78 and GRP94 knockout mice models showed that 
deletion of these genes led to a dramatic reduction in 
tumor angiogenesis and metastatic growth and increas-
ing apoptosis in tumor tissue.27,32,33 A recent interesting 
report illustrated that GRP78 knockout CD44hi/CD24lo 
phenotype cells showed very lower tumorigenesis, com-
pared with GRP78 wild-type CD44hi/CD24lo phenotype 
cells. Silencing GRP78 in CD44hi/CD24lo phenotype cells 
increased chemo-radiosensitivity and inhibited cell inva-
sion and reverse epithelial-mesenchymal transition.34 This 
may relate that GRP78 has important functions in CD44hi/
CD24lo phenotype cells like other phenotype tumor cells.
In summary, GRPs play key role in normal breast tissue, 
adult stem cells and also breast tumor cells survival and 
development. Therefore, we suggest that expression status 
of GRPs is the common aspect between distinct pheno-
type cells in breast tumor. It is important to investigate the 
linkage of GRPs and breast cancer stem cells properties 
including self-renewal, differentiation and resistance. Re-
lying on these findings, we suppose that overexpression of 
GRP78 and GRP94 in the BCSCs may be part of the intrin-
sic biology of these types of cancer cells due to its function 
in exhibition of both tumor and stem cell characteristics, 
however the reason of up-regulation is not clear yet. There 
are not significant reports concerning expression profile 
of breast cancer stem cells yet. This study is the first report 
implicating overexpression of GRPs in breast cancer stem 
cells. In many reports, GRPs have been known as an onco-
gene which is suggested to be a strong candidate targets in 
breast cancer therapy. Thus, we strongly encourage future 
investigations to clarify potential of GRPs to be used as 
target for cancer therapy. 
Conclusion
This report shows that different breast cancer cell lines 
exhibit dissimilar contents of CD44hi/CD24lo phenotype 
cells. Our findings suggest overexpression of GRP78 and 
GRP94 genes in CD44hi/CD24lo phenotype BCSCs in 
comparison with the original cell lines suggesting a re-
lationship between expression of GRPs and exhibition of 
CD44hi/CD24lo phenotype in the cell lines (Fig. 3). Given 
that GRPs share similar signature in adult stem cells, breast 
tissue and breast tumor cells gene expression profile, we 
conclude that GRPs could play an important role in exhi-
bition cancer stem cell properties and overexpression may 
be a hallmark for CD44hi/CD24lo phenotype BCSCs. 
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